| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |